Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: A new possibility for the identification and typing of anaerobic bacteria

Future Microbiology

Volumn 9, Issue 2, 2014, Pages 217-233

  Nagy, Elizabeth ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Anaerobic bacteria identification; MALDITOF; Mass spectrometry; Typing

Indexed keywords

ANAEROBIC BACTERIUM; BACTERIAL FLORA; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; COMPARATIVE STUDY; DATA BASE; FUNGUS IDENTIFICATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANAEROBIC INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; BACTEROIDES FRAGILIS; CLINICAL PRACTICE; GENE SEQUENCE; HUMAN; METAGENOMICS; PRIMARY CULTURE; SPECIES IDENTIFICATION;

RNA 16S;

BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; BACTERIAL TYPING TECHNIQUES; HUMANS; MICROBIOTA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84896822719     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.150     Document Type: Review

References (79)

1. Finegold SM, George WL. Anaerobic Infections in Humans. Academic Press, CA, USA (1989).
2. Robert R, DeRaignac A, Le Moal G, Ragot S, Grollier G. Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia. Eur. J. Microbiol. Infect. Dis. 27, 671-678 (2008).
3. Nagy E, Urban E, Nord C-E; ESCMID Study Group on Antimicrobial Resistance of Anaerobic Bacteria. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin. Microbiol. Infect. 17, 371-379 (2011). l Resistance trends in Europe during a 20-year period for Bacteroides fragilis group isolates.
4. Snydman DR, Jacobus BV, McDermott LA et al. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob. Agents Chemother. 51, 1649-1655 (2007). (Pubitemid 46744140)
5. Wexler HM. Bacteroides: the good, the bad and the nitty-gritty. Clin. Microbiol. Rev. 20, 593-621 (2007).
6. Highlander S, Versalovic J, Petrosino JF. The human microbiome. In: Manual of Clinical Microbiology (10th Edition). Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW (Eds). ASM Press, Washington DC, USA, 188-198 (2011).
7. Eckburg PB, Bik EM, Berstein CN et al. Diversity of the human intestinal microbial flora. Science 308, 1635-1638 (2005). (Pubitemid 40807514)
8. Jousimies-Somer HR, Summanen P, Citron DM, Baron EJ, Wexler HM, Finegold SM. Wadsworth-KTL Anaerobic Bacteriology Manual (6th Edition). Star Publishing Company, CA, USA (2002).
9. Jespers V, Menten J, Smet H et al. Quantification of bacterial species of the vaginal microbiome in different groups of women, using nucleic acid amplification tests. BMC Microbiol. 12, 83-94 (2012).
10. Nasidze I, Quinque D, Li J, Li M, Tang K, Stoneking M. Comparative analysis of human saliva mirobiome diversity by barcoded pyrosequencing and cloning approaches. Anal. Biochem. 391, 64-68 (2009).
11. Grice EA, Kong HH, Colan S et al. Topographical and temporal diversity of the human skin microbiome. Science 324, 1190-1192 (2009).
12. Siqueira JF Jr, Rôças IN. As-yet-uncultivated oral bacteria: breadth and association with oral and extra-oral diseases. J. Oral Microbiol. 5, 21077 (2013).
13. Han YX, Wang X. Mobile microbiome: oral bacteria in extraoral infections and inflammation. J. Dent. Res. 92, 485-491 (2013).
14. Tunney MM, Field TR, Moriarty TF et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 177, 995-1001 (2008). (Pubitemid 351717594)
15. Sweet RL. Pelvic inflammatory disease: current concepts of diagnosis and management. Curr. Infect. Dis. Rep. 14, 194-203 (2012).
16. Citron DM, Goldstein EJ, Merriam CV et al. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J. Clin. Microbiol. 45, 2819-2828 (2007). (Pubitemid 47417321)
17. Abrahamian FM, Goldstein EJ. Microbiology of animal bite wound infections. Clin. Microbiol. Rev. 24, 231-246 (2011).
18. Brook I. Microbiology and management of joint and bone infections due to anaerobic bacteria. J. Orthop. Sci. 13, 160-169 (2008). (Pubitemid 351502770)
19. Simmon KE, Mirrett S, Reller LB, Petti CA. Genotypic diversity of anaerobic isolates from bloodstream infections. J. Clin. Microbiol. 46, 1596-1601 (2008). (Pubitemid 351657200)
20. Justesen US, Skov MN, Knudsen E, Holt HM, Sogaard P, Justesen T. 16S rRNA gene sequencing in routine identification of anaerobic bacteria isolated from blood culture. J. Clin. Microbiol. 48, 946-948 (2010).
21. Wiegand PN, Nathwani D, Wilcox MH, Stephens J, Shelbaya A, Haider S. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J. Hosp. Infect. 81, 1-14 (2012).
22. La Scola B, Fournier P-E, Raoult D. Burden of emerging anaerobes in the MALDI-TOF and 16S rRNA gene sequencing era. Anaerobe 17, 106-112 (2011). l Anaerobic bacteria are more often present in human infections compared with the time when classical methods were used for culturing and identification.
23. Holdeman LV, Cato EP, Moore WEC. Anaerobe Laboratory Manual (4th Edition). Virgina Polytechnic Institute and State University, VA, USA (1977).
24. Blairon I, Maza ML, Wybo I, Pierard D, Dediste A, Vandenberg O. Vitek 2 ANC card versus BBL Crystal Anaerobe and RapID ANAII for identification of clinical anaerobic bacteria. Anaerobe 16, 355-361 (2010).
25. Kitch TT, Apelbaum PC. Accuracy and reproducibility of the 4-hour ATB 32A method for anaerobic identification. J. Clin. Microbiol. 27, 2509-2513 (1989). (Pubitemid 19251799)
26. Lee EH, Degener JE, Welling GW, Veloo AC. Evaluation of the Vitek 2 ANC card for identification of clinical isolates of anaerobic bacteria. J. Clin. Microbiol. 49, 1745-1749 (2011).
27. Citron DM. Pre-molecular identification: ignorance was bliss? Anaerobe 18, 189-191 (2012).
28. Anhalt JP, Fenselau C. Identification of bacteria using mass spectrometry. Anal. Chem. 47, 219-225 (1975).
29. Hillenkamp F, Karas M. Mass spectrometry of peptides and proteins by matrix assisted ultraviolet laser desorption/ionization. Methods Enzymol. 193, 280-295 (1990).
30. Holland RD, Wilkes JG, Rafii F et al. Rapid identification of intact whole bacteria based on spectral patterns using matrix-assisted laser deportion/ionization with time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 10, 1227-1232 (1996). (Pubitemid 26311530)
31. Krishnamurthy T, Ross PL. Rapid identification of bacteria by direct matrixassisted laser deportion /ionization with time-of-flight mass spectrometric analysis of whole cells. Rapid Commun. Mass Spectrom. 10, 1992-1996 (1996). (Pubitemid 27059022)
32. Seng P, Rolain K-M, Fournier PE, La Scola B, Brancourt M, Raoult D. MALDI-TOF-mass spectrometry applications in clinical microbiology. Future Microbiol. 5(11), 1733-1754 (2010). l Overview of the use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) in different fields of clinical microbiology.
33. Wieser A, Schneider L, Jung J, Schubert S. MALDI-TOF MS in microbiological diagnostics - identification of microorganisms and beyond (mini review). Appl. Microbiol. Biotechnol. 93, 965-974 (2012).
34. Bizzini A, Greub G. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification. Clin. Microbiol. Infect. 16, 1614-1619 (2010).
35. Emonet S, Shah HN, Cherkaoui A, Schrenzel J. Application and use of various mass spectrometry methods in clinical microbiology. Clin. Microbiol. Infect. 16, 1604-1613 (2010).
36. Shah HN, Keys CJ, Schmid O, Gharbia SE. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and proteomics: a new era in anaerobic microbiology. Clin. Infect. Dis. 35, 58-64 (2002).
37. Grosse-Herrenthey A, Maier T, Gessler F et al. Challenging the problem of clostridial identification with matrix-assisted laser desorption and ionization time-of-flight mass spectrometry. Anaerobe 14, 242-249 (2008).
38. Allen SD, Emery CL, Lyerly DM. Clostridium. In: Manual of Clinical Microbiology (8th Edition). Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (Eds). ASM Press, Washington, DC, USA, 835-856 (2003).
39. Noriyuki Nagano, Shinji Isomine, Kato H et al. Human fulminant gas gangrene caused by Clostridium chauvoei. J. Clin. Microbiol. 46(4), 1545-1547 (2008). (Pubitemid 351563614)
40. Nagy E, Becker S, Kostrzewa M, Barta N, Urbán E. The value of MALDI-TOF MS for the identification of clinically relevant anaerobic bacteria in routine laboratories. J. Med. Microbiol. 61, 1393-1400 (2012).
41. Nagy E, Maier T, Urban E, Terhes G, Kostrzewa M. Species identification of clinical isolates of Bacteroides by matrixassisted laser-desorption/ ionization time-of-flight mass spectrometry. Clin. Microbiol. Infect. 15, 796-802 (2009). l Development of database of MALDI-TOF MS for the most frequently isolated human pathogenic anaerobic genus, Bacteroides.
42. Wybo I, Soetens O, De Bel A et al. Species identification of clinical Prevotella isolates by matrix assisted laser desorption ionization time-of-flight mass spectrometry. J. Clin. Microbiol. 50, 1415-1418 (2012).
43. Stingu CS, Rodloff AC, Jentsch H, Schaumann R, Eschrich K. Rapid identification of oral anaerobic bacteria cultivated from subgingival biofilm by MALDI-TOF MS. Oral Microbiol. Immunol. 23, 372-376 (2008).
44. Veloo AC, Erhard M, Welker M, Welling GW, Degener JE. Identification of Grampositive anaerobic cocci by MALDI-TOF mass spectrometry. Syst. Appl. Microbiol. 34, 58-62 (2011).
45. Jamal WY, Shahin M, Rotimi VO. Comparison of two matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry methods and API20AN for identification of clinically relevant anaerobic bacteria. J. Med. Microbiol. 62, 540-544 (2013).
46. Knoester M, van Veen SQ, Vlaas EC, Kuijper EJ. Routine identification of clinical isolates of anaerobic bacteria: matrix-assisted laser desorption ionization-time of flight mass spectrometry performs better than conventional identification methods. J. Clin. Microbiol. 50, 1504 (2012).
47. Kierzkowska M, Majewska A, Kuthan RT, Sawicka-Grzelak A, Mlynarczyk G. A comparison of Api20A vs MALDI-TOF MS for routine identification of clinically significant anaerobic bacterial strains to the species level. J. Microbiol. Methods 92, 209-212 (2013).
48. Barreau M, Pagnier I, La Scola B. Improving the identification of anaerobes in the clinical microbiology laboratories through MALDITOF mass spectrometry. Anaerobe 22, 123-125 (2013). l Evaluation of the MALDI-TOF MS identification for the largest collection of clinical isolates of anaerobes.
49. Justesen US, Holm A, Knudsen E et al. Species identification of clinical isolates of anaerobic bacteria: a comparison of two matrix-assisted laser desorption ionization - time of flight mass spectrometry systems. J. Clin. Microbiol. 49, 4314-4318 (2011).
50. Fournier R, Wallet F, Grandbastien B et al. Chemical extraction versus direct smear for MALDI-TOF MS spectrometry for identification of anaerobic bacteria. Anaerobe 18, 294-297 (2012).
51. Veloo AC, Knoester M, Degened JE, Kuijper EJ. Comparison of two matrix-assisted laser desorption ionisation-time of flight mass spectrometry methods for the identification of clinically relevant anaerobic bacteria. Clin. Microbiol. Infect. 17, 1501-1506 (2011).
52. Martiny D, Busson L, Wybo I, Haj RA, Dediste A, Vandenberg O. Comparison of the Microflex LT and VITEK MS systems for the routine identification of bacteria by matrix-assisted laser desorption-ionisation time-of-flight mass spectrometry. J. Clin. Microbiol. 50, 1313-1325 (2012).
53. Coltella L, Mancinelli L, Onori M et al. Advancement in the routine identification of anaerobic bacteria by MALDI-TOF mass spectrometry. Eur. J. Clin. Microbiol. Infect. Dis. 32, 1138-1192 (2013).
54. Culebras E, Rodriguez-Avial I, Betriu C, Gomez M, Picazo JJ. Rapid identification of clinical isolates of Bacteroides species by matrix assisted laser-desorption/ionization time-of-flight mass spectrometry. Anaerobe 18, 163-165 (2011).
55. Federko DP, Drake SL, Stock F, Murray PR. Identification of clinical isolates of anaerobic bacteria using matrix-assisted laser desorption ionization-time of flight mass spectrometry. Eur. J. Clin. Microbiol. Infect. Dis. 31, 2257-2262 (2012).
56. Schmitt BH, Cunningham SA, Dailey AL, Gustafson DR, Patel R. Identification of anaerobic bacteria by Bruker Biotyper matrix-assisted laser desorption ionizationtime of flight mass spectrometry with on-plate formic acid preparation. J. Clin. Microbiol. 51, 782-786 (2013).
57. Garner O, Mochon A, Branda J et al. Multi-centre evaluation of mass spectrometric identification of anaerobic bacteria using VITEK® MS system. Clin. Microbiol. Infect. doi:10.1111/1469-0691.12317 (2013) (Epub ahead of print).
58. Hettick JM, Kashon ML, Slaven JE et al. Discrimination of intact mycobacteria at the strain level: a combined MALDI-TOF MS and biostatistic analysis. Proteomics 6, 6416-6625 (2006).
59. Barbuddhe SB, Maier T, Schwarz G et al. Rapid identification and typing of Listeria species by matrix assisted laser desorption ionization-time of flight mass spectrometry. Appl. Environ. Microbiol. 74, 5402-5407 (2008).
60. Wolters M, Rohde H, Maier T et al. MALDI-TOF MS fingerprinting allows for discrimination of major methicillin resistant Staphylococcus aureus lineages. Inter. J. Med. Microbiol. 301, 64-68 (2011).
61. Latigue MF, Hery-Arnaud G, Haguenoer E et al. Identification of Streptococcus agalactiae isolates from various phylogenetic lineages by matrix-assisted laser desorption ionizationtime of flight mass spectrometry. J. Clin. Microbiol. 47, 2284-2287 (2009).
62. Tanigawa K, Kawabata H, Watanabe K. Identification and typing of Lactococcus lactis by matrix assisted laser desorption ionizationtime of flight mass spectrometry. Appl. Environ. Microbiol. 76, 4055-4062 (2010).
63. Gutacker M, Valsangiacomo C, Piffaretti JC. Identification of two genetic groups in Bacteroides fragilis by multilocus enzyme electrophoresis: distribution of antibiotic resistance (cfiA, cepA) and enterotoxin (bft) encoding genes. Microbiology 146, 1241-1254 (2000). (Pubitemid 30303522)
64. Wybo I, De Bel A, Soetens O et al. Differentiation of cfiA-negative and cfiA-positive Bacteroides fragilis isolates by matrix assisted laser desorption ionizationtime of flight mass spectrometry. J. Clin. Microbiol. 49, 1961-1964 (2011). l Use of MALDI-TOF MS for typing of Bacteroides strains and differentiating the cfiA-positive isolates.
65. Nagy E, Becker S, Sóki J, Urbán E, Kostrzewa M. Differentiation of division I (cfiA-negative) and division II (cfiA-positive) Bacteroides fragilis strains by matrix assisted laser desorption ionization-time of flight mass spectrometry. J. Med. Microbiol. 60, 1584-1590 (2011).
66. Trevino M, Areses P, Penalver MD et al. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase producing strains by automated REP-PCR and MALDI-TOF. Anaerobes 18, 37-43 (2012).
67. Reil M, Erhard M, Kuijper EJ et al. Recognition of C. difficile PCR-ribotypes 001, 027, and 126/078 using an extended MALDI-TOF MS system. Eur. J. Clin. Microbiol. Infect. Dis. 30, 1431-1436 (2011).
68. Nagy E, Urban E, Becker S et al. MALDITOF MS fingerprinting facilitates rapid discrimination of phylotypes I, II and III of Propionibacterium acnes. Anaerobe 20, 20-26 (2013). l Use of MALDI-TOF MS for the typing of Propionibacterium acnes isolates.
69. Hrabák J, Walková E, Studentová V, Chudácková E, Bergerová T. Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 49, 3222-3227 (2011).
70. Burckhardt I, Zimmermann S. Using matrix assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. J. Clin. Microbiol. 49, 3321-3324 (2011).
71. Toprak NU, Uzunkaya OD, Sóki J, Soyletir G. Susceptibility profile and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in a Turkish University Hospital. Anaerobe 18, 169-171 (2012).
72. Å Johansson, Sóki J, Nagy E; on behalf of the ESCMID Study Group for Anaerobic Infections (ESGAI). Detection of carbapenemase-activity in cfiA-positive Bacteroides fragilis, using matrix-assisted laser desorption ionization - time of flight mass spectrometry (MALDI-TOF MS). Presented at: 23rd European Congress of Clinical Microbiology and Infectious Diseases, Berlin, Germany, 2013 (ePoster 682).
73. Demirev PA, Hagan NS, Antoine MD, Lin JS, Feldman AB. Establishing drug resistance in microorganisms by mass spectrometry. J. Am. Soc. Mass Spectrom. 24, 1194-1201 (2013).
74. Sparbier K, Lange C, Jung J, Wieser A, Schubert S, Kostrzewa M. MALDI Biotyper based rapid resistance detection by stable isotope labelling. J. Clin. Microbiol. 51(11), 3741-3748 (2013).
75. La Scola B, Raoult D. Direct identification of bacteria in positive blood culture bottles by matrix assisted laser desorption ionisation time-of-flight mass spectrometry. PLoS ONE 4, e8041 (2009).
76. Schubert S, Weinert K, Wagner CM et al. Novel, improved sample preparation for rapid, direct identification from positive blood cultures using matrix assisted laser desorption ionisation time-of-flight mass spectrometry. J. Mol. Diag. 13, 701-706 (2011).
77. Leli C, Cenci E, Cardaccia A et al. Rapid identification of bacterial and fungal pathogens from positive blood cultures by MALDI-TOF MS. Int. J. Med. Microbiol. 303, 205-209 (2013).
78. Moussaoui W, Jaulhac B, Hoffmann AM et al. Matrix assisted laser desorption ionisation time-of-flight mass spectrometry identifies 90% of bacteria from blood culture vials. Clin. Microbiol. Infect. 16, 1631-1638 (2010).
79. Lagier JC, Armougom F, Million M et al. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin. Microbiol. Infect. 18, 1185-1193 (2012).